title: Is sperm protein 17 a useful target for tumor immunotherapy?
authors.forename: Maurizio
authors.initials: M
authors.lastname: Chiriva-Internati
authors.forename: Fabio
authors.initials: F
authors.lastname: Grizzi
authors.forename: Barbara
authors.initials: B
authors.lastname: Franceschini
authors.forename: Paul L
authors.initials: PL
authors.lastname: Hermonat
authors.forename: Robert K
authors.initials: RK
authors.lastname: Bright
authors.forename: Klaus
authors.initials: K
authors.lastname: Bumm
authors.forename: Nicola
authors.initials: N
authors.lastname: Dioguardi
authors.forename: W Martin
authors.initials: WM
authors.lastname: Kast
mesh_terms: D000818:Animals; D000954:Antigens, Surface; D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008565:Membrane Proteins; D009101:Multiple Myeloma / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy*
chemical_list: D000954:Antigens, Surface; D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins; D008565:Membrane Proteins; C090172:SPA17 protein, human